期刊文献+

努力提高多发性骨髓瘤的基础和临床研究水平

原文传递
导出
摘要 多发性骨髓瘤(multiple myeloma,MM)是浆细胞的恶性克隆增生性疾病,以骨髓中大量克隆性浆细胞的增生和积聚,并分泌单克隆的免疫球蛋白(M蛋白)或其片段,同时伴有广泛的溶骨病变和/或骨质疏松为特征。尽管人们对于MM的认识已有150年的历史,但到目前为止MM仍然是一种不可治愈的疾病。
作者 侯健 傅卫军
出处 《国际输血及血液学杂志》 CAS 2007年第4期289-290,共2页 International Journal of Blood Transfusion and Hematology
  • 相关文献

参考文献9

  • 1Guido T. Multiple myeloma and other plasma disorders [M]// Hoffman R. Hematology-basic principles and practice. 4th ed. Elsevier, 2005: 1501-1505.
  • 2Portier M, Lees D, Caron E, et al. Up-regulation of interleukin (IL)-6 receptor gene expression in vitro and in vivo in IL-6 deprived myeloma cells. FEBS Lett, 1992, 302 ( 1 ) : 35-38.
  • 3侯健 赵君 孔宪涛.IL-6与MM增殖机制[J].中华血液学杂志,1992,13:533-535.
  • 4Fonseea R, Barlogie B, Bataille R, et al. Genetics and eytogeneties of multiple myeloma:a workshop report. Cancer Res,2004,64 (4) : 1546-1558.
  • 5Kumar S, Witzig TE, Timm M, et al. Bone marrow angiogenic ability and expression of angiogenie eytokines in myeloma: Evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression. Blood, 2004,104 (4) : 1159-1165.
  • 6Child JA, Morgan GJ, Davies FE, et al. High-dose chemotherapy with hematopoietie stem-cell rescue for multiple myeloma. N Engl J Med, 2003,348 (19) : 1875-1883.
  • 7Dimopoulos MA, Anagnostopoulos A, Weber D. Treatment of plasma cell dyscrasias with thalidomide and its derivatives. J Clin Oncol, 2003,21 (23) :4444-4454.
  • 8Richardson PG, Sonneveld P, Schuster MW, et al. BOrtezomib or high-dose dexamethasone for relapsed multiple myeloma. N Engl J Med,2005,352(24) :2487-2498.
  • 9Harousseau JL, Attal M, Leleu X, et al. Bortezomib plus dexamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma : results of an IFM phase Ⅱ study. Haematologica, 2006, 91(11) :1498-1505.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部